Targeted intra-operative radiotherapy
Targeted Intra-Operative Radiotherapy[edit | edit source]
Targeted intra-operative radiotherapy (TARGIT) is a form of radiotherapy that is administered during surgery for cancer treatment. This technique is primarily used in the treatment of breast cancer, where it offers the advantage of delivering radiation directly to the tumor bed immediately after the tumor is removed, minimizing exposure to surrounding healthy tissues.
Technique[edit | edit source]
The TARGIT procedure involves the use of a specialized device that delivers a single, high dose of radiation to the area where the tumor was located. This is typically done in the operating room immediately following the surgical removal of the tumor. The radiation is delivered using a small, spherical applicator that is placed in the tumor cavity. The applicator emits radiation in a targeted manner, focusing on the tissues at highest risk of harboring residual cancer cells.
Advantages[edit | edit source]
One of the main advantages of TARGIT is that it reduces the need for multiple sessions of external beam radiotherapy, which is the traditional method of delivering radiation therapy. This can significantly reduce the overall treatment time for patients, as well as decrease the burden on healthcare facilities. Additionally, by targeting the radiation more precisely, TARGIT minimizes the exposure of healthy tissues to radiation, potentially reducing side effects.
Applications[edit | edit source]
While TARGIT is most commonly used in the treatment of breast cancer, research is ongoing to explore its use in other types of cancer. The technique is particularly beneficial for patients who may have difficulty accessing traditional radiotherapy facilities or for those who prefer a shorter treatment regimen.
Limitations[edit | edit source]
Despite its advantages, TARGIT is not suitable for all patients. The decision to use this technique depends on various factors, including the size and location of the tumor, the patient's overall health, and the specific characteristics of the cancer. Additionally, long-term data on the outcomes of TARGIT compared to traditional radiotherapy are still being collected.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
